DISEASE SCANNER
Global Incurable Diseases Tracker
Renal Cell Carcinoma (Kidney Cancer)
The most common type of kidney cancer in adults, arising from the lining of the proximal convoluted tubule. Subtypes include clear cell (70-80%), papillary (10-15%), chromophobe (5%), and collecting duct. Often asymptomatic in early stages.
430.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1CT scan (most common)
- 2MRI
- 3Ultrasound
- 4Biopsy (selective cases)
- 5Chest X-ray (metastasis screening)
- 6Blood tests (calcium, liver function)
- 7Staging via TNM system
Prognosis
Good for localized disease (5-year survival >90%). Metastatic disease historically poor but improving with immunotherapy. Prognosis varies by histological subtype (clear cell vs papillary). Early detection significantly improves outcomes.
Prevention
- Smoking cessation
- Maintain healthy weight
- Blood pressure control
- Regular exercise
- Avoid exposure to certain chemicals
- Screening for high-risk individuals (VHL)
Research Status
Tyrosine kinase inhibitors (sunitinib, pazopanib) and mTOR inhibitors standard for advanced disease. Immune checkpoint inhibitors (nivolumab, pembrolizumab) have revolutionized treatment. Combination therapies showing improved survival. Active surveillance for small incidental masses.
Affected Countries
Sources
- https://www.cancer.org
- https://www.kidney.org
- https://www.nccn.org
- https://www.cdc.gov/
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.